Advanced search×

Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".

Jérôme J Dumortier, Emiliano E Giostra, Soraya S Belbouab, Isabelle I Morard, Olivier O Guillaud, Laurent L Spahr, Olivier O Boillot, Laura L Rubbia-Brandt, Jean-Yves JY Scoazec, and Antoine A Hadengue

Am J Gastroenterol 105(3):613-20 (2010) PMID 20040915

Fatty liver disease is a potential long-term complication of liver transplantation (LT). We therefore aimed to determine the prevalence and risk factors of liver steatosis in a large population of adult post-LT patients.

DOI: 10.1038/ajg.2009.717
Version: za2963e q8zab q8zb3 q8zc1 q8zd9 q8zee q8zf9 q8zga

Similar articles you may find interesting…

  1. Editorial: At last, time for the next transformation.
    Nicholas J NJ Talley and Joel J Richter

    Audio, Transactions of the IRE Professi... 104(12):2883-4 (2009) PMID 19956111

  2. Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activity.
    Gitte G Pedersen and Jørn J Brynskov

    Audio, Transactions of the IRE Profess... 105(7):1595-603 (2010) PMID 20087330

    Roziglitasone enemas improve impaired PPARgamma activity in inflamed colonic epithelium and have beneficial clinical effect in patients with active distal ulcerative colitis. These findings raise interest in further studies of PPARgamma ligands that exhibit their anti-inflammatory effect locally in...
  3. A novel risk score to stratify severity of Crohn's disease hospitalizations.
    Ashwin N AN Ananthakrishnan, Emily L EL McGinley, ... Kia K Saeian

    Am J Gastroenterol 105(8):1799-807 (2010) PMID 20216534

    Using administrative data, we propose a simple quantitative risk score to measure the severity of CD hospitalizations....